FDA sees possible fraud behind tainted heparin

WASHINGTON (Reuters) - The contamination of Baxter International Inc's recalled blood thinner heparin likely was done for economic reasons, the head of the U.S. Food and Drug Administration said on Tuesday.

Continue to FDA sees possible fraud behind tainted heparin on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz